1. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma
    Mian Yang et al, 2022, Computational Intelligence and Neuroscience CrossRef
  2. Establishment of rat anti-canine DEP domain containing 1B (DEPDC1B) monoclonal antibodies
    Masaya IGASE et al, 2020, Journal of Veterinary Medical Science CrossRef
  3. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
    Xiaoyan Fan et al, 2022, Frontiers in Genetics CrossRef
  4. Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance
    E. Zhou et al, 2022, Frontiers in Oncology CrossRef
  5. Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
    Xiao-Wei Dang et al, 2021, Aging CrossRef
  6. DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
    Zhenhai Zhang et al, 2022, Frontiers in Oncology CrossRef
  7. High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
    Pulin Li et al, 2022, Journal of Inflammation Research CrossRef
  8. DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway

    Shan Zhang et al, 2020, OncoTargets and Therapy CrossRef
  9. Construction of an Expression Classifier Based on an Immune-related Ten-gene Panel for Rapid Diagnosis of Papillary Thyroid Carcinoma Risks
    Hong Qiao et al, 2022, Current Bioinformatics CrossRef